Vallon Pharmaceuticals CEO David Baker chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Pennsylvania-based, privately-held clinical stage pharmaceutical company is focused on the development and commercialization of treatments for CNS disorders.
Vallon Pharmaceuticals formulating an alternative product to Adderall to limit abuse
Vallon Pharmaceuticals CEO David Baker chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Pennsylvania-based, privately-held clinical stage pharmaceutical company is focused on the development and commercialization of treatments for CNS disorders.
0 Comments